TwoStep Therapeutics Launches with $6.5 Million to Revolutionize Solid Tumor Treatment
TwoStep Therapeutics emerges as a beacon of hope in cancer treatment with the announcement of its official launch and the successful closure of a $6.5 million seed funding round led by NFX. Founded by CEO Caitlyn Miller and distinguished Stanford professors Jennifer Cochran, Ronald Levy, and Nobel Laureate Carolyn Bertozzi, TwoStep is set to revolutionize…